纳指生物科技ETF(513290)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | CGEM | Cullinan Therapeutics Inc | 108.1 | 0.07% |
| 2024-12-31 | ORKA | 方舟生物医药 | 103.44 | 0.07% |
| 2024-12-31 | KURA | Kura Oncology Inc | 103.24 | 0.07% |
| 2024-12-31 | TYRA | Tyra Biosciences Inc | 107.21 | 0.07% |
| 2024-12-31 | ERAS | Erasca Inc | 108.17 | 0.07% |
| 2024-12-31 | PRTA | Prothena Corp plc | 113.59 | 0.07% |
| 2024-12-31 | ABUS | Arbutus Biopharma Corp | 94.45 | 0.06% |
| 2024-12-31 | OMER | 奥麦罗制药 | 87.26 | 0.06% |
| 2024-12-31 | GRAL | GRAIL Inc | 91.42 | 0.06% |
| 2024-12-31 | MLYS | Mineralys Therapeutics Inc | 93.38 | 0.06% |
| 2024-12-31 | HUMA | Humacyte Inc | 99.04 | 0.06% |
| 2024-12-31 | TRDA | Entrada Therapeutics Inc | 98.57 | 0.06% |
| 2024-12-31 | ORIC | Oric Pharmaceuticals Inc | 86.8 | 0.06% |
| 2024-12-31 | MESO | Mesoblast Ltd ADR | 96.44 | 0.06% |
| 2024-12-31 | STOK | Stoke Therapeutics Inc | 89.05 | 0.06% |
| 2024-12-31 | PHAT | Phathom Pharmaceuticals Inc | 84.63 | 0.06% |
| 2024-12-31 | KROS | Keros Therapeutics Inc | 97.74 | 0.06% |
| 2024-12-31 | BCYC | Bicycle Therapeutics Ltd ADR | 93.88 | 0.06% |
| 2024-12-31 | RAPP | Rapport Therapeutics Inc | 98.91 | 0.06% |
| 2024-12-31 | VERV | Verve Therapeutics Inc | 72.78 | 0.05% |
公告&资料
